您好,欢迎来到化工原料网! [登录] [免费注册]
化工原料网
位置:首页 > 产品库 > VU0155041 sodium
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
VU0155041 sodium
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
VU0155041 sodium图片
CAS NO:1259372-69-4
包装与价格:
包装价格(元)
100mg电议
250mg电议
500mg电议

产品介绍
VU0155041 sodium 是一种有效,选择性的mGluR4混合变构激动剂/正变构调节剂 (PAM),对人和大鼠 mGluR4 的EC50值分别为 798 nM 和 693 nM。VU0155041 sodium 有潜力用于帕金森病的研究。
生物活性

VU0155041 sodium is a potent, selective positive allosteric modulator (PAM) ofmGluR4, withEC50s of 798 nM and 693 nM for human and ratmGluR4, respectively. VU0155041 has potential for the research of Parkinson's disease (PD)[1].

IC50& Target[1]

mGluR4

693 nM (EC50)

体外研究
(In Vitro)

VU0155041 (10 μM) does not affect NMDA receptor currents in striatal medium spiny neurons[1].

体内研究
(In Vivo)

VU0155041 (31 nmol, 93 nmol; i.c.v.) reverses catalepsy induced by the dopamine D2 receptor antagonist Haloperidol (1.5 mg/kg, i.p.) in rats[1].
VU0155041 (93 nmol, 316 nmol; i.c.v.) reverses Reserpine (HY-N0480) -induced akinesia in rats[1].

Animal Model:Third ventricle cannulated (TVC) Male Sprague-Dawley rats (225-255 g)[1]
Dosage:31, 93 nmol
Administration:I.c.v. injection after the the 1.5 mg/kg of haloperidol treatment 2 h
Result:Decreased the cataleptic effects of haloperidol, and the effects still presented 30 min after infusion.
分子量

338.16

Formula

C14H14Cl2NNaO3

CAS 号

1259372-69-4

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.